Jun 23, 2026 · 30 min · 13 segments
One of the greatest challenges in biomedical research isn't making a discovery—it's turning that discovery into something that improves patients' lives. The path from a promising scientific…
Alan PalkowitzGuest
Vince WongHost
Nathan BrownHostNo entities detected.
Welcome to Biosignals, the podcast powered by BioCrossroads, where we decode the pulse of Indiana's life sciences sector.
Each episode, we bring you the innovators, breakthroughs, and bold ideas shaping the future of health and science.
One of the greatest challenges in biomedical research isn't making a discovery, it's turning that discovery into something that improves patients' lives.
The path from a promising scientific breakthrough to a new therapy is long, complex, and often filled with obstacles.
That's why translational research and strong industry partnerships have become so critical to advancing innovation.
Today's guest is Dr. Alan Palkovitz, President and CEO of the Indiana Biosciences Research Institute, or IBRI.
Alan is a veteran pharmaceutical R&D leader with decades of experience in drug discovery, translational science, and therapeutic development.
Throughout his career, he has helped advance innovative therapies and led teams focused on transforming scientific insights into real-world impact.
Read the full transcript.
Create an account to read the whole episode, search across every transcript, and follow the shows you care about.
Welcome to Biosignals, the podcast powered by BioCrossroads, where we decode the pulse of Indiana's life sciences sector.
Each episode, we bring you the innovators, breakthroughs, and bold ideas shaping the future of health and science.
One of the greatest challenges in biomedical research isn't making a discovery, it's turning that discovery into something that improves patients' lives.
The path from a promising scientific breakthrough to a new therapy is long, complex, and often filled with obstacles.
That's why translational research and strong industry partnerships have become so critical to advancing innovation.
Today's guest is Dr. Alan Palkovitz, President and CEO of the Indiana Biosciences Research Institute, or IBRI.
Alan is a veteran pharmaceutical R&D leader with decades of experience in drug discovery, translational science, and therapeutic development.
Throughout his career, he has helped advance innovative therapies and led teams focused on transforming scientific insights into real-world impact.